Isolation, structural identification and cytotoxic activity of hexanic extract, cyperenoic acid, and jatrophone terpenes from Jatropha ribifolia roots  by Fernandes, Elaine de S. et al.
441
ISSN 0102-695X
DOI: 10.1590/S0102-695X2013005000026
Received 18 Sep 2012
Accepted 23 Jan 2013
Available online 26 Mar 2013
Revista Brasileira de Farmacognosia
Brazilian Journal of Pharmacognosy
23(3): 441-446, May/Jun. 2013Isolation, structural identifi cation and cytotoxic 
activity of hexanic extract, cyperenoic acid, and 
jatrophone terpenes from Jatropha ribifolia roots
Elaine de S. Fernandes,1 Fátima A. Rodrigues,1 Danilo Tófoli,2 
Paulo M. Imamura,3 João E. de Carvalho,4 Ana L. T. G. Ruiz,4 
Mary A. Foglio,4 Sandro Minguzzi,1 Rogério C. L. Silva*,1
1Departamento de Química, Unidade Universitária de Naviraí, Universidade 
Estadual de Mato Grosso do Sul, Brazil,
2Departamento de Química, Universidade Federal de Mato Grosso do Sul, Centro 
de Ciências Exatas e Tecnologia, Universidade Federal de Mato Grosso do Sul, 
Brazil,
3Departamento de Química, Universidade Estadual de Campinas, Brazil,
4Centro Pluridisciplinar de Pesquisas Químicas, Biológicas e Agrícolas, 
Universidade Estadual de Campinas, Brazil.
Abstract: The cytotoxicity of a hexanic fraction produced from the ethanolic crude 
extract, obtained from Jatropha ribifolia (Pohl) Baill, Euphorbiaceae, roots was 
evaluated against ten human cancer cell lines (MCF-7, NCI-ADR/RES, OVCAR-3, 
PC-3, HT-29, NCI-H460,786-O, UACC-62, K-562, U251) compared with 
doxorrubicine as positive control. Compounds jatrophone and cyperenoic acid were 
isolated from the hexanic extract and characterized by spectroscopic techniques 
(NMR of 1H, 13C and IR). The in vitro antiproliferative activity of jatrophone 
showed selectivity in a concentration dependent way with Total Inhibition growth 
of: glioma 0.57 μg mL-1 (U251), breast cancer 9.2 μg mL-1 (MCF-7), adriamycin-
resistant ovarian cancer 0.96 μg mL-1 (NCI-ADR/RES), kidney 4.2 μg mL-1 (786-0), 
prostate cancer 8.4 μg mL-1 (PC-3), colon cancer 16.1 μg mL-1 (HT29) and leukemia 
0.21 μg mL-1 (K-562).
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Introduction
 Bioactive terpenes have a signifi cant importance 
for the pharmaceutical industry which covers a wide 
range of diverse chemical compounds, providing 
opportunities for synthesis (Wang & Bidigare, 2005). 
The genus Jatropha is recognized as an important source 
of secondary metabolites, with mainly terpenes that are 
fairly known to this genus (Can-Aké et al., 2004).
 Jatropha ribifolia (Pohl) Baill (Euphorbiaceae) 
is found throughout the Brazilian northeastern region, 
popularly known as “pinhão-de-purga” (purgin nut). 
The latex is used by folkmedicine for treatment of 
snake bites and to treat upper tract decongestions. No 
previous reports were found describing the phytochemical 
studies of this species that is considered endemic in the 
state of Mato Grosso do Sul and known in Navirai as 
“minâncora-do-campo” (Souza & Rodal, 2010). Herein 
we report the isolation and structure elucidation of the 
compounds jatrophone and cyperenoic acid with in vitro 
antiproliferative activity.
Materials and Methods
Plant material
 Material was collected at Naviraí, Mato Grosso 
do Sul, Brazil. Voucher specimen (CGMS 31.481) was 
deposited at the Herbarium of the Institute of de Botany of 
São Paulo at the University of São Paulo, Brazil.
Isolation procedures
 Fresh roots (1.5 kg) of Jatropha ribifolia (Pohl) 
Baill., Euphorbiaceae, were ground, and extracted with 
EtOH at room temperature. The solvent was removed 
under reduced pressure yielding 386 g (25.7%) of crude 
ethanol extract. The crude extract was further partitioned 
with n-hexane and MeOH-H2O (9:1). The crude dried 
n-hexane-soluble fraction (7.75 g) was purifi ed by silica 
gel column chromatography using gradients of n-hexane/
EtOAc and EtOAc. Fractions eluted with n-hexane:EtOAc 
(20 and 25%) were grouped and purifi ed by column 
chromatography yielding jatrophone compound 1 (431.3 
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mg). Cyperenoic acid was isolated from the crude n-hexane 
extract obtained from freshly picked roots (660 g) further 
extracted with n-hexane under reflux. After removal of 
the organic solvent under reduced pressure, 8 g of the 
extract was purified by silica gel column chromatography 
affording 475.8 mg of compound 2. The active compounds 
were monitored by the in vitro antiproliferative assay.
Spectroscopic analysis
 The structures determination were based mainly 
on spectroscopic investigation of 1H and 13C NMR 
studies including HMBC (hetero nuclear multiple bond 
correlation) and COSY (proton-proton correlation) 
experimental. Infrared (IR) spectroscopy was utilized 
for identifying absorption band and gas chromatography 
coupled mass spectrometry for the structure mass-charge 
(m/z).
Biological tests
 In vitro antiproliferative assay in human cancer 
cell lines
 For the in vitro antiproliferative activity 
screening, ten cell lines were selected from human 
tumors, designated as: strains K562 (leukemia), 
MCF-7 (breast), NCI-ADR/RES (ovarian phenotype of 
resistance to multiple drugs), UACC-62 (melanoma), 
NCI-H460 (lung), PC 3 (prostate), HT29 (colon), 
OVCAR-3 (ovarian), 786-0 (kidney) and U251 (glioma), 
and a normal cell lines: VERO (monkey kidney) later 
replaced by HaCat (human keratinocyte). All cell lines 
were provided by the National Cancer Institute (NCI), 
USA. The experimental procedures were performed 
according with the literature (Skehan et al., 1990; 
Monks et al., 1991; Rubinstein et. al., 1990). 
 Stock solution of the n-hexanic extract, 
jatrophone (1) and cyperenoic acid (2) compounds (100 
mg mL-1) were prepared in dimethylsulfoxide (DMSO). 
Cell culture DMSO was diluted 400 times in RPMI/FBS/
gentamicin, to avoid toxicity. After dilution, 100 μL of 
medium containing the extract and compounds to be 
tested were added to a 96 compartments (except for the 
control) at concentrations of 0.25, 2.5, 25 and 250 μg 
mL-1. The plates were incubated for 24 h at 37 °C in a 5% 
CO2 in a humid environment. 
 Cells were cultured in RPMI-1640 medium (10 
mL), supplemented with 5% fetal calf serum (SFB). The 
vials were centrifuged (2000 g) by 4 min at 4 oC. The 
supernatant was collected and discarded and precipitated 
of cells were resuspended in 5 mL culture medium. After 
48 h, the plate T0 was fixed by adding 50 μL trichloroacetic 
acid (TCA) 50 % determining the actual amount of cells 
present at the time the samples were applied. After 48 h 
treatment 50 μL of TCA (50%) was added and incubated 
for 1 h at 4 oC. Then the plates were subjected to four 
successive washes with water to remove residues of TCA, 
medium, SFB and secondary metabolites, and then stored 
at room temperature until complete drying with further 
adition of 50 μL of sulforhodamine B (SRB) to 0.4% 
(weight/volume) dissolved in 1% acetic acid, and incubated 
at room temperature for 30 min. After wards the plates 
were washed four times consecutively with a solution of 
1% acetic acid for complete removal of residues of SRB. 
After complete drying the plates at room temperature, 
the protein bound dye was solubilized by adding 150 μL 
of 10 μM Trizma Base in pH 10.5. The cells were then 
fixed with 50% trichloroacetic acid. Cell proliferation 
was determined by spectrophotometric quantification at 
540 nm using the sulforhodamine B as dyeing reagent. 
Doxorubicin chloridate (0.025 to 25 μg mL-1) was used as 
positive control (Table 3).
 Date analysis
 The averages of the absorbance were calculated 
discounting the value the white and total growth inhibition 
(TGI) was determined by the equation: if T>C the drug 
stimulated the growth and showed not IC; if T≥To and <C, 
the drug was cytostatic and the equation used was 100 x 
[(T-To)/(C-To)]; is T<To and drug was cytocidal equation 
used was 100 x [(T-To)/(To)], being T the absorbance of 
treated cell, C the cell control and To control cells on day 
of addition of the drugs, the results was subtracted from 
100% to yield the percentage of growth. The absorbance 
data were analyzed and compiled in constructing graphs 
using the Origin 7.5 software correlating the percentage of 
inhibition or cell death at the concentration of extract and 
terpenes.
Results and Discussion
Isolation and structural identification
 The antitumor properties of species of the genus 
Jatropha have been targets of phytochemical studies. No 
previous reports on in vitro antiprolifrative activity on 
human cancer cell lines Jatropha ribifolia (Pohl) Baill., 
Euphorbiaceae, were found. Compound 1 (Figure 1) 
was obtained as colorless crystals with mp 142-144 °C. 
The GC/MS spectrum gave an [M-H] ion at m/z 312.1, 
corresponding to the molecular formula C20H24O3. The 
FTIR spectrum showed absorption at OH 3449 cm-1 
indicating the presence of OH group and carbonyl group 
at 1697 cm-1. The 1H and 13C NMR spectroscopy and 
2D NMR technique (Table 1) were compared with data 
reported by Goulart et al., (1993) and Taylor et al. (1983) 
confirming the structure which is a common compound 
among the genus Jatropha. Compound 2 (Figure 2) 
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was obtained as colorless crystals with mp 162-164 °C. 
The GC/MS spectrum gave an [M-H] ion at m/z 234.1 
corresponding to the molecular formula C15H22O2. The 
FTIR spectrum showed a broad absorption at 3430 cm-1 due 
to the presence of OH group and carbonyl group at 1674 
cm-1 indicating the presence of carboxylic acid. The 1H and 
13C NMR spectroscopy and 2D NMR technique (Table 2) 
were compared with the data reported by Pertino (2006) 
for cyperenoic acid, confirming the chemical structure. 
This is the first time where the presence of this compound 
was described in this specie. The NOESY spectrums of 
jatrophone and cyperenoic acid showed the H groups in 
proximity (Figure 1 and 2) confirming the stereochemical 
aspects observed by X-ray, for both compounds. (Pertino 
et. al., 2006; Jacobs et al., 1987).
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Figure 1. NOESY correlations for jatrophone (1).
In vitro antitumour activity 
 This is the first report exploring the in vitro 
antiproliferative activities effect of J. ribifolia extract 
and two isolated terpenic compounds, jatrophone and 
cyperenoic acid against ten human cells lines and normal 
monkey cells (VERO). A range of J. ribifolia roots extract 
and terpenes concentration (0.25 μg mL-1 to 250 μg mL-1) 
were used to investigate the relative degree of TGI against 
the following cell line: glioma (U251), melanoma (UACC-
62), breast cancer (MCF7), adriamycin-resistant ovarian 
cancer (NCI-ADR/RES), kidney (786-0), non-small lung 
cancer (NCl-H460), ovarian cancer (OVCAR-3), prostate 
cancer (PC-3), colon cancer (HT29), leukemia (K-562) 
and normal green monkey kidney cells (VERO). Figure 
3 shows the curves of the concentration response for the 
doxorrubicin control drug, hexanic extract, cyperenoic 
acid and jatrophone terpenes against human tumor cells. 
Table 3 presents the results determined by the in vitro 
antiproliferative assay with human cancer cell lines.
 The activity of hexanic extract was efficient for 
seven cell lines tested, when compared with doxorrubicine, 
with an in vitro antiproliferative activity ranging from 1.2 
to 26.5 μg mL-1. The hexanic extract’s cytocidal activity 
against tumoral cells growth was significantly efficient 
Table 1. NMR  data for jatrophone in CDCl3, with instrument operating at 250 MHz for NMR 1H and NMR 13C and 500 MHz for 2D 
COSY and HMBC.
Position 1Hb 13Cb COSY (1H-1H)b HMBC (13C-1H)
1 2.15 dd (2.15) 42.461 (42.45) H-1b, H-2  
(H-1b, H-2)
-
1.78 dd (1.79) H-1a, H-2, H-3 (H-1a, H-2, H-3)
2 2.98 m (3.00) 38.342 (38.30) H-1a, H-1b, H-3 (H-1a, H-1b) H-16
3 5.79 m (5.77) 123.760 (123.07) H-1b, H-2 (H-1b) H-17
4 - 137.078 (137.10) - H-1a, H-3, H-5
5 5.79 m (5.77) 147.143 (147.03) - H-1a, H-16
6 - 141.764 (141.75) - H-8, H-17
7 - 202.041 (201.84) - H-9, H-17
8 5.95 d (5.98) 128.722 (128.71) H-9 (H-9) -
9 6.46 d (6.48) 159.051 (158.71) H-8 (H-8) H-11b, H-18, H-19
10 - 36.642 (36.59) - H-11a, H-11b, H-8, H-18, H-19
11 2.90 d (2.91) 
2.42 d (2.44)
41.237 (41.25) - H-18, H-19
12 - 183.305 (183.12) - H-11a, H-11b, H-20
13 - 112.424 (112.36) - H-11b, H-20
14 - 203.967 (203.78) - H-20
15 - 99.799 (99.75) - H-1a, H-3
16 1.09 d (1.09) 18.974 (18.93) H-2 (H-2) H-1b
17 1.87 s (1.87) 20.738 (20.68) - -
18 1.24 s (1.26) 30.402 (30.38) H-19 (H-19) H-11a, H-19
19 1.36 s (1.37) 26.909 (26.89) H-18 (H-18) H-11b, H-18
20 1.73 s (1.74) 6.105 (6.02) H-11b -
bData in parenthesis from literature (Goulart  et al., 1997).
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(normal cell) with 1.7 μg mL-1. The activity on tumoral 
cells was also observed for the crude hexane extract due 
to the presence of jatrophone and cyperenoic acid. The 
terpenes when isolated also showed significant results 
in the bioassay under study. The cytocidal activity for 
cyperenoic acid against tumoral growth cells was efficient 
for three tested cells. The TGI for tumoral cells were 11.4 
μg mL-1 (U251), 25.1 μg mL-1 (PC-3) and 10.5 μg mL-1 
(K-562). For VERO cells 9.5 μg mL-1 was the concentration 
determined. Better results were noted for jatrophone 
(1) with selectivity in a concentration dependent way 
determined as 0.57 μg mL-1 (U251), 9.2 μg mL-1 (MCF-7), 
0.96 μg mL-1 (NCI-ADR/RES), 4.2 μg mL-1 (786-0), 8.4 
μg mL-1 (PC-3), 16.1 μg mL-1 (HT-29) and 0.21 μg mL-1 
(K-562) and VERO (normal cells). Doxorubicin drug was 
efficient to total growth inhibition in concentration 25 μg 
mL-1. 
Table 2. NMR data for cyperenoic acid in CDCl3, with instrument operating at 250 MHz for NMR 1H and NMR 13C and 500 MHz 
for 2D COSY and HMBC.
Position 1Hb 13Cb COSY (1H-1H) HMBC (13C-1H)
1 - 68.20 (68.23) - H-2a, H-2b, H-10
2 1.78 m (1.78) 1.58 m 
(1.58)
25.71 (25.74) H-2b, H-3b 
H-2a, H-3a, H-14
H-16
3 2.83 m (2.83) 2.75 m 
(2.75)
36.31 (36.33) H-2b, H-3b 
H-2a, H-3a
H-2a, H-2b,
4 - 123.07 (123.19) - -
5 - 173.09 (173.10) - -
6 2.78 m (2.77) 2.28 brd 
(2.28)
31.30 (31.34) H-6b, H-7 
H-6a
-
7 2.00 m (2.00) 48.15 (48.20) H-6a, H-8B H-9a, H-12, H-13
8 1.91 m (1.92) 1.42 m 
(1.41)
26.91 (26.96) H-8b, H-9b 
H-7, H-8a, H-9a, H-9b
H-9b, H-13
9 1.55 m (1.55) 1.17 m 
(1.17)
27.86 (27.90) H-9b, H-8b, H-10 
H-8a, H-8b, H-9a
H-10, H-14
10 2.10 m (2.10) 35.96 (36.00) H-9a H-2a, H-2b, H-9a, H-9b, H-14
11 - 41.70 (41.73) - H-2a, H-10, H-12, H-13
12 0.85 s (0.86) 26.19 (26.22) - H-13
13 1.03 s (1.03) 19.26 (19.28) - H-12
14 0.88 d (0.90) 17.96 (17.99) H-2b H-10, H-9 b
15 0.85 s (0.86) 170.71 (171.05) - -
bData in parenthesis from literature (Pertino et al., 2006). 
Table 3. Efficacy of organic extract and terpenes obtained from roots of Jatropha ribifolia and positive control doxorubicin against 
human tumor cells - Total Growth Inhibition (TGI).
TGI (μg.mL-1)
2 m a 7 4 p o h k v
Hexanic extract 1.2 15.5 9.5 9.1 >250 12.3 37.5 26.5 2.4 1.7
Cyperenoic acid 11.4 86.9 41.2 41.0 >250 25.1 65.6 57.9 10.5 9.5
Jatrophone 0.57 9.2 0.96 4.2 >250 8.4 55.8 16.1 0.21 0.21
Doxorrubicin 25 >25 >25 >25 >25 25 >25 >25 25 >25
2: U251 (glioma, SNC); m: MCF-7 (breast); a: NCl-ADR/RES (ovarian phenotype resistance to multiple drugs); 7: 786-0 (kidney); 4: NCl-H460 
(lung); p: PC-3 (prostate); o: OVCAR-3 (ovarian); h: HT-29 (colon); k: K562 (leukemia); v: Vero (monkey kidney epitelial cell).
Figure 2. NOESY correlations for cyperenoic acid (2).
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for seven strains. The necessary concentration for Total 
growth Inhibition (TGI) for tumoral cells were 1.2 μg mL-1 
(U251), 15.5 μg mL-1 (MCF-7), 9.5 μg mL-1 (NCI-ADR/
RES), 9.1 μg mL-1 (786-0), 12.3 μg mL-1 (PC-3), 26.5 μg 
mL-1 (HT29) and 2.4 μg mL-1 (K-562). The best selectivity 
was observed with glioma (U251) with 1.2 μg mL-1, above 
this concentration was observed cell death of VERO cells 
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 Further studies are necessary to better understand 
the toxic effects toward normal cells. These terpenes 
were isolated in other Euphorbiaceae species (Pertino et 
al., 2006), nevertheless no antiproliferative activities test 
were reported for cell lines mentioned herein. Previous 
authors evaluated activities against epithelial gastric cell 
line (AGS) and gastroprotecion effect (Pertino et al., 2006; 
Fröhlich et al., 2010). Cyperenoic acid (2) has been also 
isolated from different species of plants as Sandwithia 
guyanensis (Jacobs et al., 1987) Croton crassifolius 
(Boonyaratavej et al., 1988) and from Joannesia princeps 
which was evaluated for antifungic activity (Fröhlich et 
al., 2010). The preliminary results presented here show 
that jatrophone (1) and cyperenoic acid (2) could be a 
promising molecule to study for the development of a new 
cancer treatment.
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